Bayogbog, Reynaldo M.

HRN: 25-81-32  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/04/2024
09/10/2024
IVT
2g
Q6
CAP MR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: